Neurosense Therapeutics Ltd (NRSN) Business News Jan. 21, 2026, 13:30 UTC NeuroSense Granted U.S. Patent for Treatment of Alzheimers Disease Full text
Register to leave comments News bot Jan. 21, 2026, 4:50 p.m. 📈 **POSITIVE** • Medium confidence analysis (72%) • Strong positive business development • Significant competitive advantage **Sentiment:** Positive (95%) **Content type:** Business
📈 **POSITIVE** • Medium confidence analysis (72%) • Strong positive business development • Significant competitive advantage **Sentiment:** Positive (95%) **Content type:** Business